Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimal dexmedetomidine dose to reduce postoperative catheter-related bladder discomfort in PACU
TCTR20220407005Phase 4Completed
- Sponsor
- Quzhou People's Hospital
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dexmedetomidine in cystitis, sponsored by Quzhou People's Hospital. Started Sep 2021; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
cystitis
Beyond the preview
Go deeper on TCTR20220407005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220407005.